Paralysis of CD4+CD25+ regulatory T cell response in chronic autoimmune encephalomyelitis

Journal of Neuroimmunology

Volumn 187, Issue 1-2, 2007, Pages 44-54

  Matsumoto, Yoh ^a   Sakuma, Hiroshi ^a   Kohyama, Kuniko ^a   Park, Il Kwon ^a  

^a TOKYO METROPOLITAN INSTITUTE OF MEDICAL SCIENCE   (Japan)

Author keywords

Acute and chronic EAE; CD4+CD25+ regulatory T cells; Foxp3

Indexed keywords

JJ 316; MESSENGER RNA; MONOCLONAL ANTIBODY CD28; TRANSCRIPTION FACTOR FOXP3; UNCLASSIFIED DRUG;

ADOPTIVE TRANSFER; ALLERGIC ENCEPHALOMYELITIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOIMMUNE DISEASE; CD25+ T LYMPHOCYTE; CD4+ CD25+ T LYMPHOCYTE; CELL ACTIVATION; CELL COUNT; CELL FUNCTION; CELL TRANSPLANTATION; CONTROLLED STUDY; LYMPHOID ORGAN; NONHUMAN; PRIORITY JOURNAL; RAT; REGULATORY T LYMPHOCYTE;

ADOPTIVE TRANSFER; ANIMALS; ANIMALS, GENETICALLY MODIFIED; ANTIGENS, CD4; DISEASE MODELS, ANIMAL; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; FLOW CYTOMETRY; FORKHEAD TRANSCRIPTION FACTORS; INTERLEUKIN-2 RECEPTOR ALPHA SUBUNIT; LYMPH NODES; MAJOR HISTOCOMPATIBILITY COMPLEX; PARALYSIS; RATS; RATS, INBRED LEW; SPLEEN; T-LYMPHOCYTES, REGULATORY; TIME FACTORS;

EID: 34347269580     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jneuroim.2007.04.004     Document Type: Article

References (36)

1. Bas A., Forsberg G., Hammarstrom S., and Hammarstrom M.L. Utility of the housekeeping genes 18S rRNA, beta-actin and glyceraldehyde-3-phosphate-dehydrogenase for normalization in real time quantitative reverse transcriptase-polymerase chain reaction analysis of gene expression in human T lymphocytes. Scand. J. Immunol. 59 (2004) 566-573
2. Bluestone J.A., and Abbas A.K. Natural versus adaptive regulatory T cells. Nat. Med. 3 (2003) 253-257
3. Deibler G.E., Martenson R.E., and Kies M.W. Large scale preparation of myelin basic protein from central nervous tissue of several mammalian species. Prep. Biochem. 2 (1972) 139-165
4. Fontenot J.D., Gavin M.A., and Rudensky A.Y. Foxp3 programs the development and function of CD4+CD25+ regulatory T cells. Nat. Immunol. 4 (2003) 330-336
5. Furtado G.C., Curotto de Lafaille M.A., Kutchukhidze N., and Lafaille J.J. Interleukin 2 signaling is required for CD4(+) regulatory T cell function. J. Exp. Med. 196 (2002) 851-857
6. Hammond K.J.L., and Kronenberg M. Natural killer T cells: natural or unnatural regulators of autoimmunity?. Curr. Opin. Immunol. 15 (2003) 683-689
7. Hori S., and Sakaguchi S. Foxp3: a critical regulator of the development and function of regulatory T cells. Microbes Infect. 6 (2004) 745-751
8. Hori S., Haury M., Coutinho A., and Demengeot J. Specificity requirements for selection and effector functions of CD25+4+ regulatory T cells in anti-myelin basic protein T cell receptor transgenic mice. Proc. Natl. Acad. Sci. U. S. A. 99 (2002) 8213-8218
9. Huan J., Culbertson N., Spencer L., Bartholomew R., Burrows G.G., Chou Y.K., Bourdette D., Ziegler S.F., Offner H., and Vandenbark A.A. Decreased FOXP3 levels in multiple sclerosis patients. J. Neurosci. Res. 81 (2005) 45-52
10. Jahng A.W., Maricic I., Pedersen B., Burdin N., Naidenko O., Kronenberg M., Koezuka Y., and Kumar V. Activation of natural killer T cells potentiates or prevents experimental autoimmune encephalomyelitis. J. Exp. Med. 194 (2001) 1789-1799
11. Khattri R., Cox T., Yasayko S.A., and Ramsdell F. An essential role for Scurfin in CD4+CD25+ T regulatory cells. Nat. Immunol. 4 (2003) 337-342
12. Kohm A.P., Carpentier P.A., Anger H.A., and Miller S.D. CD4+CD25+ regulatory T cells suppress antigen-specific autoreactive immune responses and central nervous system inflammation during active experimental autoimmune encephalomyelitis. J. Immunol. 169 (2002) 4712-4716
13. Lalive P.H., Menge T., Delarasse C., Della Gaspera B., Pham-Dinh D., Villoslada P., von Budingen H.C., and Genain C.P. Antibodies to native myelin oligodendrocyte glycoprotein are serologic markers of early inflammation in multiple sclerosis. Proc. Natl. Acad. Sci. U. S. A. 103 (2006) 2280-2285
14. + T regulatory cells suppress naive and memory T cell proliferation and can be expanded in vitro without loss of function. J. Exp. Med. 193 (2001) 1295-1302
15. Lin C.H., and Hunig T. Efficient expansion of regulatory T cells in vitro and in vivo with a CD28 superagonist. Eur. J. Immunol. 33 (2003) 626-638
16. Matsumoto Y., and Fujiwara M. The immunopathology of adoptively transferred experimental allergic encephalomyelitis (EAE) in Lewis rats. Part 1. Immunohistochemical examination of developing lesion of EAE. J. Neurol. Sci. 77 (1987) 35-47
17. Matsumoto Y., Kohyama K., Aikawa Y., Shin T., Kawazoe Y., Suzuki Y., and Tanuma N. Role of natural killer cells and TCR gamma delta T cells in acute autoimmune encephalomyelitis. Eur. J. Immunol. 28 (1998) 1681-1688
18. McGeachy M.J., Stephens L.A., and Anderton S.M. Natural recovery and protection from autoimmune encephalomyelitis: contribution of CD4+CD25+ regulatory cells within the central nervous system. J. Immunol. 175 (2005) 3025-3032
19. H2 bias of natural killer T cells. Nature 413 (2001) 531-534
20. O'Garra A., and Vieira P. Regulatory T cells and mechanism of immune system control. Nat. Med. 10 (2004) 801-805
21. Ohmori K., Hong Y., Fujiwara M., and Matsumoto Y. In situ demonstration of proliferating cells in the rat central nervous system during experimental autoimmune encephalomyelitis. Evidence suggesting that most infiltrating T cells do not proliferate in the target organ. Lab. Invest. 66 (1992) 54-62
22. Sakaguchi S. Naturally arising CD4+ regulatory t cells for immunologic self-tolerance and negative control of immune responses. Annu. Rev. Immunol. 22 (2004) 531-562
23. Sakaguchi S. Naturally arising Foxp3-expressing CD25+CD4+ regulatory T cells in immunological tolerance to self and non-self. Nat. Immunol. 6 (2005) 345-352
24. Sakaguchi S., Toda M., Asano M., Itoh M., Morse S.S., and Sakaguchi N. T cell-mediated maintenance of natural self-tolerance: its breakdown as a possible cause of various autoimmune diseases. J. Autoimmun. 9 (1996) 211-220
25. Sakuma H., Kohyama K., Jee Y., and Matsumoto Y. Tracking of Vbeta 8.2-positive encephalitogenic T cells by CDR3 spectratyping and subsequent Southern blot hybridization in Lewis rats after neuroantigen sensitization. J. Immunol. 173 (2004) 4516-4522
26. Sakuma H., Kohyama K., Park I.K., Miyakoshi A., Tanuma N., and Matsumoto Y. Clinicopathological study of a myelin oligodendrocyte glycoprotein-induced demyelinating disease in LEW.1AV1 rats. Brain 127 (2004) 2201-2213
27. Shi F., Ljunggren H., and Sarvetnick N. Innate immunity and autoimmunity: from self-protection to self-destruction. Trends Immunol. 22 (2001) 97-101
28. Shin T., Kojima T., Tanuma N., Ishihara Y., and Matsumoto Y. The subarachnoid space as a site for precursor T cell proliferation and effector T cell selection in experimental autoimmune encephalomyelitis. J. Neuroimmunol. 56 (1995) 171-177
29. Storch M.K., Stefferl A., Brehm U., Weissert R., Wallstrom E., Kerschensteiner M., Olsson T., Linington C., and Lassmann H. Autoimmunity to myelin oligodendrocyte glycoprotein in rats mimics the spectrum of multiple sclerosis pathology. Brain Pathol. 8 (1998) 681-694
30. Tacke M., Hanke G., Hanke T., and Hunig T. CD28-mediated induction of proliferation in resting T cells in vitro and in vivo without engagement of the T cell receptor: evidence for functionally distinct forms of CD28. Eur. J. Immunol. 27 (1997) 239-247
31. Tang Q., Henriksen K.J., Bi M., Finger E.B., Szot G., Ye J., Masteller E.L., McDevitt H., Bonyhadi M., and Bluestone J.A. In vitro-expanded antigen-specific regulatory T cells suppress autoimmune diabetes. J. Exp. Med. 199 (2004) 1455-1465
32. Viglietta V., Baecher-Allan C., Weiner H.L., and Hafler D.A. Loss of functional suppression by CD4+CD25+ regulatory T cells in patients with multiple sclerosis. J. Exp. Med. 199 (2004) 971-979
33. von Budingen H.C., Hauser S.L., Fuhrmann A., Nabavi C.B., Lee J.I., and Genain C.P. Molecular characterization of antibody specificities against myelin/oligodendrocyte glycoprotein in autoimmune demyelination. Proc. Natl. Acad. Sci. U. S. A. 99 (2002) 8207-8212
34. von Budingen H.C., Hauser S.L., Ouallet J.C., Tanuma N., Menge T., and Genain C.P. Epitope recognition on the myelin/oligodendrocyte glycoprotein differentially influences disease phenotype and antibody effector functions in autoimmune demyelination. Eur. J. Immunol. 34 (2004) 2072-2083
35. Zhang B., Yamamura T., Kondo T., Fujiwara M., and Tabira T. Regulation of experimental autoimmune encephalomyelitis by natural killer (NK) cells. J. Exp. Med. 186 (1997) 1677-1687
36. + regulatory T cells. Int. Immunol. 16 (2004) 249-256